1. Prognostic significance of LAT1 expression in pleural mesothelioma
   Ryo Taguchi et al, 2024, Heliyon CrossRef
2. Association of KDR (rs2071559, rs1870377), CFH (rs1061170, rs1410996) genes variants and serum levels with pituitary adenoma
   Akvile Bruzaite et al, 2024, Molecular Genetics & Genomic Medicine CrossRef
3. Extended ICI treatment after first‐line chemoimmunotherapy could predict the clinical benefit of ramucirumab plus docetaxel in advanced non‐small lung cancer: Post hoc analysis from NEJ051 (REACTIVE study)
   Ou Yamaguchi et al, 2024, Thoracic Cancer CrossRef
4. Computer‐Aided Design of VEGFR‐2 Inhibitors as Anticancer Agents: A Review
   Abdullahi Ibrahim Uba, 2024, Journal of Molecular Recognition CrossRef
5. The Role of Angiogenesis Mediators in the Mobilization of Early and Late Endothelial Progenitor Cells from the Bone Marrow in Coronary Heart Disease
   Svetlana P. Chumakova et al, 2024, Annals of the Russian academy of medical sciences CrossRef
6. Clinicopathological impact of VEGFR2 and VEGF‐C in patients with EGFR‐major mutant NSCLC receiving osimertinib
   Kyoichi Kaira et al, 2023, Thoracic Cancer CrossRef